Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis.
Kranidioti H, Chatzievagelinou C, Protopapas A, Papatheodoridi M, Zisimopoulos K, Evangelidou E, Antonakaki P, Vlachogiannakos J, Triantos C, Elefsiniotis I, Goulis J, Mela M, Anagnostou O, Tsoulas C, Deutsch M, Papatheodoridis G, Manolakopoulos S. Kranidioti H, et al. Among authors: triantos c. Ann Gastroenterol. 2018 Sep-Oct;31(5):598-603. doi: 10.20524/aog.2018.0293. Epub 2018 Jul 19. Ann Gastroenterol. 2018. PMID: 30174397 Free PMC article.
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection.
Manolakopoulos S, Karatapanis S, Elefsiniotis J, Mathou N, Vlachogiannakos J, Iliadou E, Kougioumtzan A, Economou M, Triantos C, Tzourmakliotis D, Avgerinos A. Manolakopoulos S, et al. Among authors: triantos c. Am J Gastroenterol. 2004 Jan;99(1):57-63. doi: 10.1046/j.1572-0241.2003.04021.x. Am J Gastroenterol. 2004. PMID: 14687142
Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
Manolakopoulos S, Bethanis S, Elefsiniotis J, Karatapanis S, Triantos C, Sourvinos G, Touloumi G, Economou M, Vlachogiannakos J, Spandidos D, Avgerinos A, Tzourmakliotis D. Manolakopoulos S, et al. Among authors: triantos c. Aliment Pharmacol Ther. 2006 Mar 15;23(6):787-95. doi: 10.1111/j.1365-2036.2006.02806.x. Aliment Pharmacol Ther. 2006. PMID: 16556181
Ultrasound-guided liver biopsy in real life: comparison of same-day prebiopsy versus real-time ultrasound approach.
Manolakopoulos S, Triantos C, Bethanis S, Theodoropoulos J, Vlachogiannakos J, Cholongitas E, Sideridis M, Barbatis C, Piperopoulos P, Spiliadi C, Papadimitriou N, Roukounakis N, Tzourmakliotis D, Avgerinos A, Burroughs A. Manolakopoulos S, et al. Among authors: triantos c. J Gastroenterol Hepatol. 2007 Sep;22(9):1490-3. doi: 10.1111/j.1440-1746.2007.04992.x. Epub 2007 Jun 15. J Gastroenterol Hepatol. 2007. PMID: 17573828
Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices.
Vlachogiannakos J, Kougioumtzian A, Triantos C, Viazis N, Sgouros S, Manolakopoulos S, Saveriadis A, Markoglou C, Economopoulos T, Karamanolis DG. Vlachogiannakos J, et al. Among authors: triantos c. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1479-87. doi: 10.1111/j.1365-2036.2007.03539.x. Epub 2007 Oct 5. Aliment Pharmacol Ther. 2007. PMID: 17919272 Clinical Trial.
Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
Manolakopoulos S, Bethanis S, Koutsounas S, Goulis J, Vlachogiannakos J, Christias E, Saveriadis A, Pavlidis C, Triantos C, Christidou A, Papatheodoridis G, Karamanolis D, Tzourmakliotis D. Manolakopoulos S, et al. Among authors: triantos c. Aliment Pharmacol Ther. 2008 Feb 1;27(3):266-73. doi: 10.1111/j.1365-2036.2007.03567.x. Epub 2007 Nov 5. Aliment Pharmacol Ther. 2008. PMID: 17988233
183 results